Stephen Liu

Stephen Liu: Interesting look at immediate versus deferred systemic therapy in patients with pleural mesothelioma at Clinical Lung Cancer

Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter:

“Certainly confounders here, but interesting look at immediate versus deferred systemic therapy in patients with pleural mesothelioma at Clinical Lung Cancer. In this group, 58% of deferred patients eventually had systemic therapy. OS longer in deferred group (20.6m vs 11.5m).”

Visit the article website.
Source: Stephen Liu/X

cancer Clinical Lung Cancer immediate systemic therapy Lung cancer OncoDaily Oncology overall survival pleural mesothelioma Stephen Liu systemic therapy